For example, in lung cancer, the incidence of CHEK2 mutations and copy-number variants is 0.99% (22/2219) and 0.54% (6/1112), respectively (Catalogue of Somatic Mutations in Cancer; http://cancer.sanger.ac.uk/cosmic). This evidence concerns the gene CHEK2 and lung carcinoma.